Global Transcriptome Sequencing Competitive Landscape Professional Research Report 2025
Research SummaryTranscriptome sequencing is a molecular biology technique that involves the high-throughput sequencing of RNA molecules in a biological sample. The transcriptome represents the complete set of RNA transcripts, including messenger RNA (mRNA), non-coding RNA, and other RNA species, present in a cell or a population of cells at a specific moment. Transcriptome sequencing provides a comprehensive snapshot of gene expression patterns, allowing researchers to analyze which genes are active and to what extent. This technology is instrumental in understanding cellular processes, identifying differentially expressed genes, and unraveling the molecular mechanisms underlying various biological phenomena, including development, disease, and response to environmental stimuli. RNA sequencing technologies, such as RNA-Seq, have become powerful tools in genomics and biomedical research, providing insights into the dynamic nature of gene expression and contributing to advancements in personalized medicine and functional genomics.
According to DIResearch's in-depth investigation and research, the global Transcriptome Sequencing market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, BGI Genomics, Zhijiang Biology, Novogene Co., Ltd, Macrogen, Tsingke Biotechnology Co., Ltd. etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Transcriptome Sequencing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Transcriptome Sequencing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Transcriptome Sequencing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Transcriptome Sequencing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Transcriptome Sequencing Include:
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Transcriptome Sequencing Product Segment Include:
Coding RNA
Noncoding RNA
Transcriptome Sequencing Product Application Include:
Biomedical Field
Non-medical Field
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Transcriptome Sequencing Industry PESTEL Analysis
Chapter 3: Global Transcriptome Sequencing Industry Porter’s Five Forces Analysis
Chapter 4: Global Transcriptome Sequencing Major Regional Market Size and Forecast Analysis
Chapter 5: Global Transcriptome Sequencing Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Transcriptome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Transcriptome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Transcriptome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Transcriptome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Transcriptome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Transcriptome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Transcriptome Sequencing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources